https://www.selleckchem.com/products/ki696.html
A XGBoost-based based clinical model on admission might be used as an effective tool to identify patients at high risk of critical illness. A XGBoost-based based clinical model on admission might be used as an effective tool to identify patients at high risk of critical illness. Platinum-based chemotherapy remains the essential therapy for small cell lung cancer (SCLC). Here, we conducted a statistical analysis to explore whether the curative efficacy of 2-cycle platinum-based chemotherapy can predict the survival of patients with SCLC. F
Like
Comment
Share
